Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for inflammatory knee osteoarthritis
ACTRN12618001656224Phase 2Recruiting
- Sponsor
- University of Tasmania
- Start
- Mar 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Diacerein with Placebo (2 arms). Primary endpoint: Knee pain by visual analogue scale. Started Mar 2019; status: recruiting.
02
Drugs
diacerein
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12618001656224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001656224.